BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 21244928)

  • 1. Methods and devices for local drug delivery in coronary and peripheral arteries.
    Wilensky RL; March KL; Gradus-Pizlo I; Spaedy AJ; Hathaway DR
    Trends Cardiovasc Med; 1993; 3(5):163-70. PubMed ID: 21244928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Concepts for local therapy of restenosis].
    Riessen R; Oberhoff M; Karsch KR
    Z Kardiol; 1996; 85 Suppl 1():87-98. PubMed ID: 8882829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local drug delivery - the early Berlin experience: single drug administration versus sustained release.
    Speck U; Scheller B; Rutsch W; Laule M; Stangl V
    EuroIntervention; 2011 May; 7 Suppl K():K17-22. PubMed ID: 22027723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmaceutical approaches to colon targeted drug delivery systems.
    Chourasia MK; Jain SK
    J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local delivery of biodegradable microparticles containing colchicine or a colchicine analogue: effects on restenosis and implications for catheter-based drug delivery.
    Gradus-Pizlo I; Wilensky RL; March KL; Fineberg N; Michaels M; Sandusky GE; Hathaway DR
    J Am Coll Cardiol; 1995 Nov; 26(6):1549-57. PubMed ID: 7594084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymeric endoluminal gel paving: therapeutic hydrogel barriers and sustained drug delivery depots for local arterial wall biomanipulation.
    Slepian MJ
    Semin Interv Cardiol; 1996 Mar; 1(1):103-16. PubMed ID: 9552500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug release kinetics from stent device-based delivery systems.
    Tesfamariam B
    J Cardiovasc Pharmacol; 2008 Feb; 51(2):118-25. PubMed ID: 18287878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-eluting stents.
    García-García HM; Vaina S; Tsuchida K; Serruys PW
    Arch Cardiol Mex; 2006; 76(3):297-319. PubMed ID: 17091802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a functionalized polymer for stent coating in the arterial delivery of small interfering RNA.
    San Juan A; Bala M; Hlawaty H; Portes P; Vranckx R; Feldman LJ; Letourneur D
    Biomacromolecules; 2009 Nov; 10(11):3074-80. PubMed ID: 19761207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status of biodegradable stents.
    Tanguay JF; Zidar JP; Phillips HR; Stack RS
    Cardiol Clin; 1994 Nov; 12(4):699-713. PubMed ID: 7850839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Local drug administration systems, preclinical and clinical use: perspectives and limitations].
    Gonschior P; Wilensky R; March K; Höfling B
    Z Kardiol; 1996 Mar; 85(3):155-65. PubMed ID: 8659193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local methylprednisolone delivery using a BiodivYsio phosphorylcholine-coated drug-delivery stent reduces inflammation and neointimal hyperplasia in a porcine coronary stent model.
    Huang Y; Liu X; Wang L; Verbeken E; Li S; De Scheerder I
    Int J Cardiovasc Intervent; 2003; 5(3):166-71. PubMed ID: 12959735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of delivery and local drug delivery technologies.
    Bailey SR
    Semin Interv Cardiol; 1996 Mar; 1(1):17-23. PubMed ID: 9552481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel biodegradable polymer-coated, paclitaxel-eluting stent inhibits neointimal formation in porcine coronary arteries.
    Buszman P; Milewski K; Zurakowski A; Pajak J; Liszka Ł; Buszman P; Musioł E; AbuSamra M; Trznadel S; Kałuza G
    Kardiol Pol; 2010 May; 68(5):503-9. PubMed ID: 20491008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new intra-arterial delivery platform for pro-arteriogenic compounds to stimulate collateral artery growth via transforming growth factor-beta1 release.
    Grundmann S; van Royen N; Pasterkamp G; Gonzalez N; Tijsma EJ; Piek JJ; Hoefer IE
    J Am Coll Cardiol; 2007 Jul; 50(4):351-8. PubMed ID: 17659203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene delivery from a DNA controlled-release stent in porcine coronary arteries.
    Klugherz BD; Jones PL; Cui X; Chen W; Meneveau NF; DeFelice S; Connolly J; Wilensky RL; Levy RJ
    Nat Biotechnol; 2000 Nov; 18(11):1181-4. PubMed ID: 11062438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New routes for delivery of anti-epileptic medications.
    Fisher RS; Chen DK
    Acta Neurol Taiwan; 2006 Dec; 15(4):225-31. PubMed ID: 17214084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymer coatings and delayed arterial healing following drug-eluting stent implantation.
    Byrne RA; Joner M; Kastrati A
    Minerva Cardioangiol; 2009 Oct; 57(5):567-84. PubMed ID: 19838148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapamycin analogs for stent-based local drug delivery. Everolimus- and tacrolimus-eluting stents.
    Grube E; Buellesfeld L
    Herz; 2004 Mar; 29(2):162-6. PubMed ID: 15054588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.